Olaf Stuve

Olaf Stuve

UNVERIFIED PROFILE

Are you Olaf Stuve?   Register this Author

Register author
Olaf Stuve

Olaf Stuve

Publications by authors named "Olaf Stuve"

Are you Olaf Stuve?   Register this Author

100Publications

1709Reads

39Profile Views

Trials and therapies in secondary progressive MS, simplified.

Nat Rev Neurol 2019 Aug;15(8):431-432

Department of Neurology and Neurotherapeutics, the University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41582-019-0233-xDOI Listing
August 2019

α4-integrin deficiency in B cells does not affect disease in a T-cell-mediated EAE disease model.

Neurol Neuroimmunol Neuroinflamm 2019 Jul 16;6(4):e563. Epub 2019 Apr 16.

Department of Neurology and Neurotherapeutics (R.Z.H., P.C.C., W.A.M.-L., R.D., V.G., D.T.O., O.S.) and Department of Pathology (E.H.), University of Texas Southwestern Medical Center, Dallas; Department of Pathology and Genomic Medicine (T.N.E.), Houston Methodist Hospital; Neurology Section (O.S.), VA North Texas Health Care System, Medical Service; and Department of Neurology (O.S.), Klinikum Rechts der Isar, Technische Universität München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481229PMC
July 2019

Immunological Aspects of Approved MS Therapeutics.

Front Immunol 2019 11;10:1564. Epub 2019 Jul 11.

Department of Neurology, Klinikum Rechts der Isar, Technische Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.01564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637731PMC
July 2019

The role of B cells in multiple sclerosis: Current and future therapies.

Cell Immunol 2019 May 21;339:10-23. Epub 2018 Oct 21.

Department of Biology, University of Texas at San Antonio, TX 78249, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2018.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540809PMC
May 2019

Clinical trials in multiple sclerosis: potential future trial designs.

Ther Adv Neurol Disord 2019 13;12:1756286419847095. Epub 2019 May 13.

Neurology Section, VA North Texas Health Care System, Medical Service, 500 South Lancaster Rd., Dallas, TX 75216, USA Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center, Dallas, TX Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756286419847095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535717PMC
May 2019

Simplification of combination antiretroviral therapy (cART) and the brain-a real-life experience.

J Neurovirol 2019 Apr 9;25(2):174-182. Epub 2019 Jan 9.

Southwestern Medical Center, University of Texas, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13365-018-0701-xDOI Listing
April 2019

Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.

Neurology 2019 Mar 8;92(10):451-452. Epub 2019 Feb 8.

From the Department of Neurology (T.B.), Medical University of Vienna, Austria; Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center, Dallas; Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas, TX; and Department of Neurology (O.S.), Klinikum rechts der Isar, Technische Universität München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007022DOI Listing
March 2019

Evolution of clinical trials in multiple sclerosis.

Ther Adv Neurol Disord 2019 21;12:1756286419826547. Epub 2019 Feb 21.

Neurology Section, VA North Texas Health Care System, Medical Service, 4500 South Lancaster Rd., Dallas, TX 75216, USADepartment of Neurology, Klinikum rechts der Isar, Technische Universität München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756286419826547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391540PMC
February 2019

Natalizumab: Perspectives from the Bench to Bedside.

Cold Spring Harb Perspect Med 2018 12 3;8(12). Epub 2018 Dec 3.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas 75390.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/cshperspect.a029066DOI Listing
December 2018

TLR3 agonism re-establishes CNS immune competence during 4-integrin deficiency.

Ann Clin Transl Neurol 2018 Dec 30;5(12):1543-1561. Epub 2018 Oct 30.

Department of Neurology and Neurotherapeutics University of Texas Southwestern Medical Center Dallas Texas.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/acn3.664
Publisher Site
http://dx.doi.org/10.1002/acn3.664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292184PMC
December 2018

PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcome.

J Neuroimmunol 2018 10 25;323:53-55. Epub 2018 Jul 25.

Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, United States; Department of Neurology, VA North Texas Health Care System, Medical Service, Dallas, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2018.07.012DOI Listing
October 2018

Clinical trials in multiple sclerosis: milestones.

Ther Adv Neurol Disord 2018 9;11:1756286418785499. Epub 2018 Jul 9.

Neurology Section, VA North Texas Health Care System, Medical Service, 4500 South Lancaster Rd, Dallas, TX 75216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756286418785499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048605PMC
July 2018

Emerging drugs for primary progressive multiple sclerosis.

Expert Opin Emerg Drugs 2018 06 24;23(2):97-110. Epub 2018 Apr 24.

a Department of Neurology and Neurotherapeutics , University of Texas Southwestern Medical Center , Dallas , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2018.1463370DOI Listing
June 2018

Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE.

Neurol Neuroimmunol Neuroinflamm 2018 Mar 17;5(2):e437. Epub 2018 Jan 17.

Department of Neurology and Neurotherapeutics (R.Z.H., W.A.M.-L., R.D., P.D.C., O.S.), University of Texas Southwestern Medical Center, Dallas; Department of Biostatistics (G.C.), University of Alabama at Birmingham; The Moody Foundation Flow Cytometry Facility (N.L.), Children's Research Institute, University of Texas Southwestern Medical Center, Dallas; Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas, TX; and Department of Neurology (O.S.), Klinikum rechts der Isar, Technische Universität München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773844PMC
March 2018

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.

Ther Adv Neurol Disord 2018 21;11:1756286418761697. Epub 2018 Mar 21.

Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756286418761697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865455PMC
March 2018

B-cell-targeted therapies in relapsing forms of MS.

Neurol Neuroimmunol Neuroinflamm 2017 Nov 23;4(6):e405. Epub 2017 Oct 23.

Department of Neurology (D.B., E.P.F., S.J.P.), and Department of Laboratory Medicine and Pathology (S.J.P.), Mayo Clinic, Rochester, MN; Department of Biology (T.F.), University of Texas at San Antonio; Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center, Dallas; Neurology Section (O.S.), VA North Texas Health Care System, Dallas VA Medical Center, TX; and Department of Neurology (O.S.), Klinikum rechts der Isar, Technische Universität München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656409PMC
November 2017

Normal intrathecal leukocyte cell number and composition do not decrease the incidence of post-lumbar puncture headache.

J Neuroimmunol 2017 09 30;310:69-71. Epub 2017 Jun 30.

Pfizer, Cambridge, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2017.06.011DOI Listing
September 2017

Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease.

J Neuroimmunol 2017 08 26;309:100-110. Epub 2017 May 26.

Department of Neurology and Neurotherapeutics, the University of Texas Southwestern Medical Center at Dallas, USA; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Germany; Neurology Section, VA North Texas Health Care System, Medical Service Dallas, VA Medical Center, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2017.05.017DOI Listing
August 2017

Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project.

J Am Coll Radiol 2017 Mar 5;14(3):371-379.e1. Epub 2016 Dec 5.

Department of Radiology, University of Michigan, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2016.09.037DOI Listing
March 2017

The major histocompatibility complex and antibody-mediated limbic encephalitis.

Ann Neurol 2017 02;81(2):181-182

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24861DOI Listing
February 2017

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Neurology 2017 Feb 1;88(9):842-852. Epub 2017 Feb 1.

From the Colorado Blood Cancer Institute (R.A.N.), Denver; Baylor College of Medicine (G.J.H.), Houston, TX; Ohio State University (M.K.R., S.M.D.), Columbus; MD Anderson Cancer Research Center (U.P.), Houston, TX; Rho, Inc. (K.C.S.), Chapel Hill, NC; National Institute of Allergy and Infectious Diseases (L.M.G.), National Institutes of Health, Bethesda, MD; Division of Brain Sciences (P.A.M.), Imperial College London, UK; City of Hope National Medical Center (H.O.), Duarte, CA; Immune Tolerance Network (P.H.S.), University of California San Francisco; University of Texas Southwestern (O.S.), Dallas; NeuroRx (D.L.A.), McGill University, Montreal, Canada; Fred Hutchinson Cancer Research Center (G.E.G.), University of Washington (M.H.W., A.W., G.H.K.); and Swedish Hospital Medical Center (J.D.B.), Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868PMC
February 2017

Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology.

J Immunol 2017 02;198(4):1381-1386

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX 75390; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1601358DOI Listing
February 2017

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis.

Degener Neurol Neuromuscul Dis 2016 17;6:95-109. Epub 2016 Nov 17.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DNND.S85747DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053094PMC
November 2016

B cell-directed therapies in multiple sclerosis.

Neurodegener Dis Manag 2016 ;6(1):37-47

Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675 München, Germany.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/nmt.15.67
Publisher Site
http://dx.doi.org/10.2217/nmt.15.67DOI Listing
October 2016

Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.

Expert Rev Neurother 2016 10 1;16(10):1131-9. Epub 2016 Sep 1.

c Department of Neurology and Neurotherapeutics , UT Southwestern Medical Center , Dallas , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2016.1227242DOI Listing
October 2016

Targeting "bad" B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?

Neurol Neuroimmunol Neuroinflamm 2016 Oct 21;3(5):e283. Epub 2016 Sep 21.

Department of Biology (T.G.F.), University of Texas at San Antonio; Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center; and Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032664PMC
http://dx.doi.org/10.1212/NXI.0000000000000283DOI Listing
October 2016

Diagnostic and therapeutic strategies for management of autoimmune encephalopathies.

Expert Rev Neurother 2016 08 30;16(8):937-49. Epub 2016 May 30.

a Department of Neurology and Neurotherapeutics , UT Southwestern Medical Center , Dallas , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2016.1189328DOI Listing
August 2016

Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.

Curr Opin Neurol 2016 06;29(3):278-85

Department of Neurology and Neurotherapeutics, Neurology Section, University of Texas Southwestern Medical Center, VA North Texas Health Care System, Medical Service, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000321DOI Listing
June 2016

Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.

Curr Opin Neurol 2016 06;29(3):272-7

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000320DOI Listing
June 2016

Managing Disability in Progressive Multiple Sclerosis.

Curr Treat Options Neurol 2016 Jun;18(6):27

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11940-016-0412-7DOI Listing
June 2016

Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.

JAMA Neurol 2016 05;73(5):496-7

Department of Neurology and Neuroscience, The Ohio State University, Columbus.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.4841DOI Listing
May 2016

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of 'Chinese restaurant syndrome'.

J Neurol 2016 May 8;263(5):1027-1028. Epub 2016 Apr 8.

Department of Neurology, Medical Faculty, Heinrich-Heine University, Moorenstrasse 5, 40224, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-016-8110-7DOI Listing
May 2016

In Memoriam: John F. Kurtzke, MD (1926-2015): A Founding Father of Neuroepidemiology and Pioneer of Modern Clinical Trial Design.

JAMA Neurol 2016 Apr;73(4):482-3

Department of Neurology, Wayne State School of Medicine, Detroit, Michigan6Department of Immunology and Microbiology, Wayne State School of Medicine, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.0030DOI Listing
April 2016

Primary progressive multiple sclerosis--why we are failing.

Lancet 2016 Mar 28;387(10023):1032-1034. Epub 2016 Jan 28.

Neurology Section, VA North Texas Health Care System, Medical Service Dallas, VA Medical Center, Dallas, TX, 75216, USA; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)00158-6DOI Listing
March 2016

Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.

J Neurol 2016 Mar 25;263(3):606-10. Epub 2016 Feb 25.

Neurology Section, VA North Texas Health Care System, Medical Service, 4500 South Lancaster Rd., Dallas, TX, 75216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-015-7999-6DOI Listing
March 2016

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.

Neurotherapeutics 2016 Jan;13(1):58-69

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-015-0409-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720678PMC
January 2016

Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.

JAMA Neurol 2015 Oct;72(10):1105-6

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas3Neurology Section, Medical Service, VA North Texas Health Care System, Dallas4Department of Neurology, Klinikum rechts der Isar, Technische Universitä

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.1805DOI Listing
October 2015

Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.

Neuropsychiatr Dis Treat 2015 18;11:2405-14. Epub 2015 Sep 18.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA ; Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, USA ; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/NDT.S90473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581781PMC
October 2015

The spectrum of autoimmune encephalopathies.

J Neuroimmunol 2015 Oct 28;287:93-7. Epub 2015 Aug 28.

Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01655728153003
Publisher Site
http://dx.doi.org/10.1016/j.jneuroim.2015.08.014DOI Listing
October 2015

Update on biomarkers in neuromyelitis optica.

Neurol Neuroimmunol Neuroinflamm 2015 Aug 23;2(4):e134. Epub 2015 Jul 23.

Stanford University (E.M., M.H.H.), Stanford, CA; Johns Hopkins University (M.L.), Baltimore, MD; University of Oxford (P.J.W.), UK; Tohoku University (D.K.S.), Sendai, Japan; University of São Paulo (D.K.S.), Brazil; University of Colorado (J.L.B.), Denver; Mt. Sinai University (G.R.J.), New York, NY; Thomas Jefferson University (D.C.H.), Philadelphia, PA; IDIBAPS (A.S.), Barcelona, Spain; Montreal Neurological Institute and Hospital (A.B.-O.), McGill University, Montreal, Quebec, Canada; Research Institute and Hospital of National Cancer Center (H.J.K.), Goyang, Korea; KS Hegde Medical Academy (L.P.), Nitte University, Mangalore, India; Oxford University Hospital (M.I.L.), Oxford, UK; University of Southern Denmark (N.A.), Odense; Vejle Hospital (N.A.), Denmark; University Hospital (N.K.), Marrakech, Morocco; MS Center (R.H.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Service de Neurologie A (R.M.), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France; Molecular Neuroimmunology (S.J.), Department of Neurology, University Hospital Heidelberg, Germany; Tandem Labs (J.M.), San Diego, CA; University of Michigan Medical School (T.J.S.), Ann Arbor, MI; and David Geffen School of Medicine (M.R.Y.), University of California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516398PMC
August 2015

Natalizumab to fingolimod: Questions answered, unanswered, and unasked.

Neurology 2015 Jul 29;85(1):14-5. Epub 2015 May 29.

From the Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center, Dallas; the Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas; the Department of Neurology (O.S.), Klinikum rechts der Isar, Technische Universität München, Germany; the Department of Neurology (D.B.), Oregon Health & Science University, Portland; and the Multiple Sclerosis Center of Excellence-West (D.B.), VA Portland Health Care Center, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001722DOI Listing
July 2015

B lymphocytes in neuromyelitis optica.

Neurol Neuroimmunol Neuroinflamm 2015 Jun 7;2(3):e104. Epub 2015 May 7.

Departments of Neurology and Ophthalmology and Neuroscience Program (J.L.B.), University of Colorado, Denver; Department of Neurology (K.C.O.), Yale University School of Medicine, New Haven, CT; Neuroimmunology Unit (A.B.-O.), Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada; Department of Neurology (S.S.Z., H.-C.v.B.), UCSF School of Medicine, San Francisco, CA; Department of Neurology (B.H.), Technische Universität München, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Immunology (T.F.T.), Duke University Medical Center, Durham, NC; Departments of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Medicine (M.R.Y.), Divisions of Molecular Medicine and Infectious Diseases, University of California, Los Angeles; Harbor-UCLA Medical Center (M.R.Y.), Torrance, CA; Departments of Ophthalmology and Visual Sciences and Internal Medicine (T.J.S.), University of Michigan Medical School, Ann Arbor; and Institute of Neuropathology (C.S.), University Medical Center, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426682PMC
June 2015

In Memoriam: Jean Lindenmann (1924-2015): A Circuitous Interfering Power in Neurology.

Authors:
Olaf Stüve

JAMA Neurol 2015 Jun;72(6):728-9

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas2Neurology Section, VA North Texas Health Care System, Medical Service, Dallas3Department of Neurology, Klinikum rechts der Isar, Technische Universitä

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.0439DOI Listing
June 2015

Multiple sclerosis drugs: how much bang for the buck?

Lancet Neurol 2015 May 1;14(5):460-1. Epub 2015 Apr 1.

Department of Biostatistics, Section on Research Methods and Clinical Trials, University of Alabama at Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(15)00016-2DOI Listing
May 2015

Spinal gout: A rare cause of paraplegia.

Neurol India 2015 Mar-Apr;63(2):284-5

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0028-3886.156318DOI Listing
May 2015

Treatment decisions for patients with active multiple sclerosis.

JAMA Neurol 2015 Apr;72(4):387-9

Department of Systems Medicine, Multiple Sclerosis Clinical and Research Center, Tor Vergata University and Hospital, Rome, Italy6Istituto Di Ricovero e Cura a Carattere Scientifico, Fondazione Santa Lucia, Centro Europeo di Ricerca sul Cervello, Rome, It.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.4494DOI Listing
April 2015

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

Mult Scler 2015 Mar 22;21(3):282-93. Epub 2014 Dec 22.

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514564490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429166PMC
March 2015

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

Mult Scler 2015 Mar 22;21(3):342-9. Epub 2014 Dec 22.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514564486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429167PMC
March 2015

Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Expert Rev Clin Immunol 2015 Jan 18;11(1):69-91. Epub 2014 Dec 18.

University of Texas San Antonio - Biology, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2015.991315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326231PMC
January 2015

The genetics of natalizumab hypersensitivity: One learns to itch where one can scratch.

Neurol Neuroimmunol Neuroinflamm 2014 Dec 11;1(4):e52. Epub 2014 Dec 11.

Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center, Dallas, TX; Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas, TX; Department of Neurology (O.S., B.H.), Klinikum rechts der Isar, Technische Universität München, Germany; and Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268034PMC
December 2014

Heat exposure and bicycling trigger recurrent aseptic meningitis: a case report.

BMC Neurol 2014 Dec 31;14:230. Epub 2014 Dec 31.

Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-014-0230-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301064PMC
December 2014

Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.

J Neuroimmunol 2014 Nov 2;276(1-2):232-5. Epub 2014 Sep 2.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, TX, USA; Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, USA; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.08.624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296723PMC
November 2014

Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.

J Neuroimmunol 2014 Nov 30;276(1-2):9-17. Epub 2014 Aug 30.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, TX, USA; Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, USA; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01655728140087
Publisher Site
http://dx.doi.org/10.1016/j.jneuroim.2014.08.622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301841PMC
November 2014

Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?

Mult Scler 2014 Sep 8;20(10):1304-5. Epub 2014 May 8.

VA North Texas Health Care System, Medical Service Dallas, VA Medical Center/University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA/Klinikum rechts der Isar, Technische Universität München, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514531843DOI Listing
September 2014

Isoniazid in autoimmunity: a trigger for multiple sclerosis?

Ther Adv Neurol Disord 2014 Sep;7(5):253-6

Neurology Section, VA North Texas Health Care System, Medical Service, 4500 South Lancaster Rd, Dallas, TX 75216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756285614540361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206619PMC
September 2014

Does natalizumab therapy benefit patients with multiple sclerosis?

JAMA Neurol 2014 Aug;71(8):945-6

Section on Research Methods and Clinical Trials, Department of Biostatistics, University of Alabama at Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.1201DOI Listing
August 2014

Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers.

JAMA Neurol 2014 Jul;71(7):905-12

Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.395DOI Listing
July 2014

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Neurology 2014 Jul 28;83(3):278-86. Epub 2014 May 28.

From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117366PMC
July 2014

Alemtuzumab: the advantages and challenges of a novel therapy in MS.

Neurology 2014 Jul 11;83(1):87-97. Epub 2014 Jun 11.

From the Department of Neurology and Center for Neuropsychiatry (T.M., O.S., B.C.K., H.-P.H.), Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany; and the Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center at Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000540DOI Listing
July 2014

Multiple sclerosis: Natalizumab to fingolimod--the washout whitewash.

Nat Rev Neurol 2014 Jun 20;10(6):311-3. Epub 2014 May 20.

Neurology Section, VA North Texas Health Care System, Medical Service Dallas, VA Medical Centre, 4500 South Lancaster Road, Dallas, TX 75216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2014.82DOI Listing
June 2014

Immunopathogenesis of neuromyelitis optica.

Adv Immunol 2014 ;121:213-42

Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA; Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, Texas, USA; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany; Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-800100-4.00006-4DOI Listing
May 2014

Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations.

Ther Adv Neurol Disord 2014 May;7(3):177-87

Neurology Section, VA North Texas Health Care System, Medical Service, 4500 South Lancaster Road, Dallas, TX 75216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756285614521889DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994922PMC
May 2014

Multiple sclerosis disease progression and paradichlorobenzene: a tale of mothballs and toilet cleaner.

JAMA Neurol 2014 Feb;71(2):228-32

Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas2Neurology Section, VA North Texas Health Care System, Medical Service, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2013.4395DOI Listing
February 2014

Teriflunomide for the treatment of multiple sclerosis.

Clin Neurol Neurosurg 2013 Dec;115 Suppl 1:S90-4

Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2013.09.030DOI Listing
December 2013

A bird's-eye view of T cells during natalizumab therapy.

Neurology 2013 Oct 18;81(16):1372-3. Epub 2013 Sep 18.

From the Institute of Clinical Neuroimmunology (R.H.), Ludwig Maximilians University, Munich; Munich Cluster for Systems Neurology (SyNergy) (R.H.), Germany; and University of Texas Southwestern Medical Center and Neurology Section (O.S.), VA North Texas Health Care Systems, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3182a84207DOI Listing
October 2013

Progressive multiple sclerosis: desperately seeking remedy.

Lancet Neurol 2013 Sep 16;12(9):840-841. Epub 2013 Jul 16.

NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(13)70181-9DOI Listing
September 2013

Management of secondary progressive multiple sclerosis: prophylactic treatment-past, present, and future aspects.

Curr Treat Options Neurol 2013 Jun;15(3):241-58

Department of Neurology, Medical University of Vienna, Vienna, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11940-013-0233-xDOI Listing
June 2013

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Nat Rev Neurol 2013 May 26;9(5):267-76. Epub 2013 Mar 26.

Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Germany. stangel.martin@ mh-hannover.de

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2013.41DOI Listing
May 2013

A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.

J Neuroimmunol 2013 Jan 1;254(1-2):63-8. Epub 2012 Oct 1.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2012.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084825PMC
January 2013

Objective characterization of the relative afferent pupillary defect in MS.

J Neurol Sci 2012 Dec 29;323(1-2):193-200. Epub 2012 Sep 29.

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022510X120050
Publisher Site
http://dx.doi.org/10.1016/j.jns.2012.09.015DOI Listing
December 2012